Evofem Biosciences, Inc.
(NASDAQ : EVFM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. 10.73%61.500.0%$1907.60m
REGNRegeneron Pharmaceuticals, Inc. 5.98%612.812.5%$1175.40m
GILDGilead Sciences, Inc. 3.33%77.831.0%$1168.63m
AMGNAmgen, Inc. 2.49%229.701.3%$672.54m
VRTXVertex Pharmaceuticals, Inc. 3.81%287.961.9%$606.67m
NVAXNovavax, Inc. 2.68%46.04102.0%$590.02m
BIIBBiogen, Inc. 2.19%307.091.6%$417.42m
ILMNIllumina, Inc. -2.67%363.053.5%$387.48m
SRNESorrento Therapeutics, Inc. 2.02%5.051.8%$306.68m
ALXNAlexion Pharmaceuticals, Inc. 4.79%119.902.0%$292.13m
SGENSeattle Genetics, Inc. 3.74%157.216.1%$269.08m
AAgilent Technologies, Inc. 1.67%88.141.6%$202.48m
BMRNBioMarin Pharmaceutical, Inc. 0.90%106.554.3%$186.35m
CODXCo-Diagnostics, Inc. 3.03%18.000.0%$173.36m
INCYIncyte Corp. 1.35%101.912.5%$166.15m

Company Profile

Evofem Biosciences, Inc. develops therapeutic solutions to meet sexual and reproductive health needs of women. Its product include Amphora Contraceptive for the prevention of pregnancy, antimicrobial drug product for the prevention of sexually transmitted infections and Antimicrobial Drug product to prevent the reoccurrence of bacterial vaginosis. The company was founded in 2007 and is headquartered in San Diego, CA.